FILANA THERAPEUTICS: Nasdaq Biotech Eyeing Breakthroughs in Alzheimer’s Treatment
Discover how Filana Therapeutics, a Nasdaq‑listed biotech, is tackling Alzheimer’s with innovative R&D, stock volatility, and potential upside for investors.
2 minutes to read
